Feasibility study on a non-mammalian marine collagen which has similar properties to mammalian collagen.

与哺乳动物胶原蛋白具有相似特性的非哺乳动物海洋胶原蛋白的可行性研究。

• 批准号: 102947
• 金额: $ 8.19万
• 依托单位: MIKOTA LTD
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2017
• 资助国家: 英国
• 起止时间: 2017 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=102947
• 关键词: Feasibility; study; non; mammalian; marine

Mikota Ltd is a startup in the high value niche market of novel biomaterials from the marine environment. This project is for a feasibility study into a new and novel non-mammalian marine collagen which is thermally stable in its native form, in line with bovine collagen, the gold standard for biomaterials. This will be a product that, from early indications, has all the benefits of bovine collagen with the added advantage of being non-mammalian. The biomaterials market has actively demanded and pursued non-mammalian alternatives in the collagen range, but the present technologies have fallen short on a critical deliverable, which is thermal stability. Fish collagen has a very low melting point, as do the so called "collagen-like" jellyfish products on the market, which also struggle to actually be identified as collagen. The project will include early stage technical feasibility work undertaken by our industry partner, Collagen Solutions plc, and includes market analysis and customer questionnaire work being done by Mikota Ltd in conjunction with Collagen Solutions and select potential customers and agents.

Mikota Ltd是一家在来自海洋环境的新型生物材料的高价值利基市场上的初创公司。这个项目是为了研究一种新的、新型的非哺乳动物海洋胶原蛋白的可行性，这种胶原蛋白在其天然形态下是热稳定的，符合生物材料的黄金标准牛胶原蛋白。从早期的迹象来看，这将是一种产品，它不仅具有牛胶原蛋白的所有好处，而且还具有非哺乳动物的优势。生物材料市场积极需求和追求非哺乳动物的胶原蛋白替代品，但目前的技术在一项关键的可交付产品上做得不够，那就是热稳定性。鱼胶原蛋白的熔点很低，市场上所谓的类胶原蛋白水母产品也是如此，这些产品也很难真正被鉴定为胶原蛋白。该项目将包括由我们的行业合作伙伴胶原解决方案公司承担的早期技术可行性工作，并包括Mikota Ltd与胶原解决方案以及挑选潜在客户和代理商一起进行的市场分析和客户问卷调查工作。